Christopher Moore

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana et al. · Immunity · 2017 · 665 citations · Full text

Medicine, Cancer Biology, Oncology +17

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Mark S. Graham, Carole H. Sudre, Anna May et al. · The Lancet Public Health · 2021 · 343 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

Míriam Molina‐Arcas, Christopher Moore, Sareena Rana et al. · Science Translational Medicine · 2019 · 220 citations

Medicine, Oncology, Pharmacology +16

The CATERPILLER Protein Monarch-1 Is an Antagonist of Toll-like Receptor-, Tumor Necrosis Factor α-, and Mycobacterium tuberculosis-induced Pro-inflammatory Signals

Kristi L. Williams, John D. Lich, Joseph A. Duncan et al. · Journal of Biological Chemistry · 2005 · 219 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

Esther Castellano, Clare Sheridan, May Zaw Thin et al. · Cancer Cell · 2013 · 190 citations · Full text

Medicine, Cancer Biology, Oncology +15